Increasing use of biological drugs is expected to drive the growth of global oral drug delivery market during the forecast period.
According to TechSci Research report, “Global Oral Drug Delivery Market, By Formulation (Tablets, Capsules, Drops, Liquid or Syrup), By Type (Controlled Release, Orodispersible Tablets, Others), By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others), By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others), By Region, By Company, Competition, Forecast & Opportunities, 2026”, Global oral drug delivery market is expected to witness a CAGR of around 7% over the forecast period. Mounting demand for effective drug delivery mechanisms is one of the major factors accounting for the growth of global oral drug delivery market. Moreover, ongoing technological advancements is expected to bode well for the growth of global oral drug delivery market through the forecast period. In addition to this, surging use of biological drugs is positively influencing the growth of global oral drug delivery market in the years to come. Along with this, supportive government funding is positively contributing to the market growth in the next 5 years. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for pharmaceutical drugs largely in infectious application, which is further bolstering the market growth. However, there are certain factors that might act as major impediments to the growth of global oral drug delivery market during the forecast period such as risk associated with the side effects of drugs and needle stick injuries.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on“ Global Oral Drug Delivery Market “
Global oral drug delivery market can be segmented based on formulation, type, therapy area, end user, company, and region. Considering the end user, the market is fragmented into hospitals, ambulatory surgical centers, diagnostic centers, clinics, others. The hospital segment dominated the global oral drug delivery market until 2020 and is further anticipated to maintain its dominance during the forecast period as well. This is because of rising occurrence of diseases across the globe which in turn increases the need for treatment at hospitals utilizing drug delivery technology. Besides, ambulatory surgical centers are expected to grow at a high pace in the next 5 years as they deploy drug delivery technology for administering the drugs to patients on an immediate basis or under emergency conditions.
Novartis AG, Biocon Ltd., NovoNordisk A/S, F.Hoffmann-La Roche Ltd., Bayer AG, Emishphere Technologies Inc., Enteris Biopharma Inc., Merrion Pharmaceuticals Plc., Amgen Inc., Pfizer Inc., among others are the leading players operating in global oral drug delivery market. The leading players are adopting several growth strategies to enhance the market scenario of oral drug delivery. Other competitive strategies include product launches; mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diverse their product portfolio in order to strengthen their market position.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=7236
customers can also request for 10% free customization on this report.
North America is forecasted to dominate the global oral drug delivery market in the next 5 years on account of upsurge in the number of pharmaceutical companies in the region. Furthermore, increasing incidence of chronic diseases including cancer, respiratory allergies, and diabetes are also contributing to the growing trend. Asia pacific region is forecasted to register highest growing CAGR over the years to come which can be attributed to rising focus to boost biologic sector coupled with increasing technological advancements in oral drug delivery technology.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Oral Drug Delivery Market, By Formulation (Tablets, Capsules, Drops, Liquid or Syrup), By Type (Controlled Release, Orodispersible Tablets, Others), By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others), By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others), By Region, By Company, Competition, Forecast & Opportunities, 2026” has evaluated the future growth potential of global oral drug delivery market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global oral drug delivery market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017